Somatic ARID1A, MLL3 and NF1 mutations were found in at least one component in three, six and four breast tumours, respectively, and the presence of these mutations was unrelated to the HER2 status (Fig. S2, Table 2). This evidence concerns the gene NF1 and breast neoplasm.